LATEST NEWS

International collaboration provides important piece of COVID-19 puzzle
Researchers comb through hundreds of studies to find clues to beating COVID-19
Study finds robust antiviral T cell response in humans with COVID-19 and detects substantial crossreactivity in unexposed individuals; in a piece of good news provides a benchmark for testing of vaccine candidates.
Antibody therapeutics will likely be a critical tool for protecting frontline healthcare workers and those at most risk of SARS-CoV-2 infection
To aid vaccine design, researchers will investigate how a diverse population fights off viral attack
Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates